Trial Profile
Comparative registry of everolimus eluting stent and zotarolimus eluting stent in diffuse long coronary artery lesion (EXLONG registry); A multicenter, cohort observational study.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms EXLONG
- 24 Nov 2011 New trial record